The global flow cytometry market is expected
to reach USD 8.0 billion by 2025, according to a new study by Grand View
Research, Inc. The increasing incidence of infectious diseases and cancer is
expected to upsurge the demand for flow cytometers for use in disease diagnosis
over the coming years. In addition, higher number of physicians is inclined
toward the usage of autologous and allogenic stem cell therapy, due to adverse
effects caused by chemotherapy & radiation therapy in the treatment of cancer,
thereby affecting the growth of this market.
Moreover, rising demand for
point-of-care testing in chronic diseases management is expected to fuel the
demand for cytometry techniques. Rising implementation of microfluidic
miniature flow cytometry in point-of-care diagnostics is the factor augmenting
the future growth. Increasing R&D initiatives by various key players for
the development of multicolor assays and advanced reagents for analysis are
anticipated to boost the usage rate. Advancement in technology for the purpose
of enhanced accuracy, portability, and cost-effectiveness is expected to serve
this market with lucrative growth opportunities.
Small-size high-throughput
cytometers are expected to gain popularity over the coming years due to associated
benefits such as ease in use and cost-effectiveness. Furthermore, improvement
in fluorescent dyes & introduction of bench top cytometers are the other
growth propellers. For instance, multicolor flow cytometry coupled with
multiple lasers is the fastest growing application segment, which finds
extensive applications in the field of R&D innovations in new drug
development and is adopted by many contract research organizations.
Browse full research report on Global Flow Cytometry Market: http://www.grandviewresearch.com/industry-analysis/flow-cytometry-market
Further Key Findings From
the Study Suggest:
- Bead-based flow cytometry is anticipated to witness lucrative growth rate over the forecast period owing to increasing advancement in molecular engineering & monoclonal antibody production
- Reagents & consumables are expected to be the fastest growing segment as of 2016 due to extensive utilization in molecular diagnostics
- Clinical diagnosis market is driven by factors such as increasing demand for cost-effective disease diagnosis and associated benefits of these assays in disease detection
- The largest market share of commercial organizations can be attributed to the rising large-scale production of proteins, cell line development, and other biologicals coupled with the growing demand for cell sorting and analysis techniques
- Asia Pacific regional market is presumed to witness the fastest growth owing to increasing supportive government initiatives for flourishing biotech industry coupled with growing awareness about the applications of flow cytometers
- Multinational players collaborating with local diagnostic companies and healthcare institutions in developing countries such as India & Brazil, target the disease population and are expected to increase market penetration
Grand View Research has segmented the flow cytometry market
on the basis of technology, product & services, application, end-use, and
region:
Global Flow Cytometry Application Outlook (Revenue,
USD Million, 2014 - 2025)
- Cell-based
- Bead-based
Global Flow Cytometry Product & Services Outlook
(Revenue, USD Million, 2014 - 2025)
- Instruments
- Reagent & consumables
- Software
- Accessories
- services
Global Flow Cytometry Application Outlook (Revenue,
USD Million, 2014 - 2025)
- Research
- Pharmaceutical
- Drug discovery
- Stem cells
- In vitro toxicity
- Apoptosis
- Cell sorting
- Cell cycle analysis
- Immunology
- Cell viability
- Industrial
- Clinical
- Cancer
- Organ transplantation
- Immunodeficiency
- Hematology
Global Flow Cytometry End-use Outlook (Revenue, USD
Million, 2014 - 2025)
- Commercial organizations
- Hospitals
- Academic institutes
- Clinical testing labs
Flow Cytometry Regional Outlook (Revenue, USD Million,
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment